← Leaderboards
Mark Roschewski
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “S Lymphoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
- Richard L Schilsky · University Of Chicago$120,036,663
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
- Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Charles A Coltman · Southwest Oncology Group$55,198,633
Research focus
S LymphomaMolecularLymphomaLarge Cell Diffuse Non-Hodgkin&AposB-Cell LymphomasPredictive SignatureGene Expression ProfileResistanceImmune Checkpoint InhibitorResponseDisease RemissionHuman Herpesvirus 4Follicular LymphomaTumor DnaSafetyHistologicToxic EffectCellsIn Complete RemissionTumorDisease ProgressionImmune Response GenesAgammaglobulinaemia Tyrosine KinaseImmune
Grant awards (17)
Pathway inhibitors in Lymphomas$1,616,572
ZIA · FY2025 · CA · contact PI
Molecular Biology of Lymphoma$1,581,430
ZIA · FY2025 · CA · contact PI
Checkpoint inhibitor treatment for EBV+ lymphoma among HIV+ individuals$316,286
ZIA · FY2025 · CA · contact PI
Pathway inhibitors in Lymphomas$1,541,889
ZIA · FY2024 · CA · contact PI
Molecular Biology of Lymphoma$1,508,370
ZIA · FY2024 · CA · contact PI
Checkpoint inhibitor treatment for EBV+ lymphoma among HIV+ individuals$301,675
ZIA · FY2024 · CA · contact PI
Checkpoint inhibitor treatment for EBV+ lymphoma among HIV+ individuals$1,364,053
ZIA · FY2023 · CA · contact PI
Molecular Biology of Lymphoma$682,027
ZIA · FY2023 · CA · contact PI
Pathway inhibitors in Lymphomas$682,027
ZIA · FY2023 · CA · contact PI
Pathway inhibitors in Lymphomas$1,231,483
ZIA · FY2022 · CA · contact PI
Molecular Biology of Lymphoma$820,988
ZIA · FY2022 · CA · contact PI
Pathway inhibitors in Lymphomas$794,573
ZIA · FY2021 · CA · contact PI
Molecular Biology of Lymphoma$529,715
ZIA · FY2021 · CA · contact PI
Pathway inhibitors in Lymphomas$331,530
ZIA · FY2020 · CA · contact PI
Molecular Biology of Lymphoma$221,021
ZIA · FY2020 · CA · contact PI
Pathway inhibitors in Lymphomas$254,824
ZIA · FY2019 · CA · contact PI
Molecular Biology of Lymphoma$169,882
ZIA · FY2019 · CA · contact PI